This finding is in line with the results of the study by T’Hart et al. [12], in which, although positive effects of the G-allele of rs7202877 on GLP-1-stimulated insulin secretion in individuals without diabetes were reported, no robust evidence to support the association between this genetic variant and response to GLP-1 RA treatment was provided. The gene discussed is GCG; the disease is diabetes mellitus.